Loading company…
NetTargets uses AI and systems biology to identify drug candidates.
NetTargets develops drug discovery software with a drug database and mechanism analysis platform. Its technology provides predictions to support research and development decisions. Founded in 2019, the company is based in Daejeon, South Korea. It raised KRW 6 billion in Series A funding in July 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in